Two Classes of DNA Gyrase Inhibitors Elicit Distinct Evolutionary Trajectories Toward Resistance in Gram-Negative Pathogens.

Leyn, Semen A; Kent, James E; Zlamal, Jaime E; Elane, Marinela L; Vercruysse, Maarten; Osterman, Andrei L

Leyn, Semen A; Kent, James E; Zlamal, Jaime E; Elane, Marinela L; Vercruysse, Maarten; Osterman, Andrei L.

Afiliação

Leyn SA; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Kent JE; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Zlamal JE; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Elane ML; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Vercruysse M; Roche Pharma Research and Early Development, Immunology, Inflammation, and Infectious Diseases, Basel, Switzerland.
Osterman AL; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.

bioRxiv ; 2023 Sep 21.

Article em En | MEDLINE | ID: mdl-37425702

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google